Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Ранг среди акций
#2196
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Цена акции
$3.40
Рыночная капитализация
$9.07B
Изменение (1 день)
-1.61%
Изменение (1 год)
-16.08%
Страна
CN
Торговля Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Категория
Healthcare
EPS для Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Shanghai Fosun Pharmaceutical (Group) Co., Ltd., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Shanghai Fosun Pharmaceutical (Group) Co., Ltd. с 2001 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2025 | $0.18 | 27.37% |
| 2024 | $0.14 | 13.37% |
| 2023 | $0.13 | -39.36% |
| 2022 | $0.21 | -28.79% |
| 2021 | $0.29 | 32.98% |
| 2020 | $0.22 | 17.25% |
| 2019 | $0.19 | 19.99% |
| 2018 | $0.16 | -20.29% |
| 2017 | $0.20 | 11.99% |
| 2016 | $0.17 | 5.76% |
| 2015 | $0.16 | 10.98% |
| 2014 | $0.15 | 26.81% |
| 2013 | $0.12 | -8.73% |
| 2012 | $0.13 | 32.54% |
| 2011 | $0.10 | 38.88% |
| 2010 | $0.07 | -64.74% |
| 2009 | $0.20 | 264.76% |
| 2008 | $0.05 | 16.31% |
| 2007 | $0.05 | 142.71% |
| 2006 | $0.02 | 58.68% |
| 2005 | $0.01 | -22.93% |
| 2004 | $0.02 | -23.41% |
| 2003 | $0.02 | 72.27% |
| 2002 | $0.01 | 2.59% |
| 2001 | $0.01 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
